Literature DB >> 17512415

Snapshot: genetic mouse models of cancer.

Lars Zender, Johannes Zuber, Scott W Lowe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512415      PMCID: PMC4591003          DOI: 10.1016/j.cell.2007.05.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  16 in total

1.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

4.  Temporal dissection of p53 function in vitro and in vivo.

Authors:  Maria A Christophorou; Dionisio Martin-Zanca; Laura Soucek; Elizabeth R Lawlor; Lamorna Brown-Swigart; Emmy W Verschuren; Gerard I Evan
Journal:  Nat Genet       Date:  2005-05-29       Impact factor: 38.330

5.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

Authors:  J Jonkers; R Meuwissen; H van der Gulden; H Peterse; M van der Valk; A Berns
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

6.  Reversible tumorigenesis by MYC in hematopoietic lineages.

Authors:  D W Felsher; J M Bishop
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

7.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

Authors:  J M Adams; A W Harris; C A Pinkert; L M Corcoran; W S Alexander; S Cory; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

8.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

9.  Tumor spectrum analysis in p53-mutant mice.

Authors:  T Jacks; L Remington; B O Williams; E M Schmitt; S Halachmi; R T Bronson; R A Weinberg
Journal:  Curr Biol       Date:  1994-01-01       Impact factor: 10.834

10.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

Authors:  Sunil R Hingorani; Emanuel F Petricoin; Anirban Maitra; Vinodh Rajapakse; Catrina King; Michael A Jacobetz; Sally Ross; Thomas P Conrads; Timothy D Veenstra; Ben A Hitt; Yoshiya Kawaguchi; Don Johann; Lance A Liotta; Howard C Crawford; Mary E Putt; Tyler Jacks; Christopher V E Wright; Ralph H Hruban; Andrew M Lowy; David A Tuveson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

View more
  4 in total

Review 1.  Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches.

Authors:  Tim F Greten; Xin W Wang; Firouzeh Korangy
Journal:  Gut       Date:  2015-02-09       Impact factor: 23.059

Review 2.  Genetically modified mouse models in cancer studies.

Authors:  Javier Santos; Pablo Fernández-Navarro; María Villa-Morales; Laura González-Sánchez; José Fernández-Piqueras
Journal:  Clin Transl Oncol       Date:  2008-12       Impact factor: 3.405

Review 3.  Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response.

Authors:  Michel DuPage; Tyler Jacks
Journal:  Curr Opin Immunol       Date:  2013-03-04       Impact factor: 7.486

4.  Rapid and non-enzymatic in vitro retrieval of tumour cells from surgical specimens.

Authors:  Brigitte Mack; Carola Eggert; Katharina Eder; Sannia Imrich; Philipp Baumeister; Ulrich Harréus; Olivier Gires
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.